ARCHIVES

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

This article is from The Cancer Letter archive.

Vol. 29 No. 36 | October 3, 2003

Download PDF Visit The Full Archive

Related Articles

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

Sausville to lead clinical research at Maryland.

December 5, 2003

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: House Bill Boosts NIH Funding By $1.2 Billion; ASCO Counted More Than 17,000 Registrants

June 26, 1998

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996